Table 1.
Demographic information for participants with useable EEGs
| PMS (n = 26) | TD (n = 15) | |
|---|---|---|
| Sex | 10 (M) 16 (F) | 9 (M) 6 (F) |
| Collection site* | ||
| Icahn School of Medicine at Mount Sinai | 11 (42.3%) | 10 (33%) |
| Rush University Medical Center | 8 (30.8%) | 5 (67%) |
| Boston Children’s Hospital | 7 (26.9%) | 0 (0%) |
| Net type | ||
| Hydrocel 128 | 18 (69%) | 10 (33%) |
| Biosemi 32 | 8 (31%) | 5 (67%) |
| Age (years) | 9.5 ± 4.25 | 10.0 ± 2.39 |
| ASD diagnosis | ||
| ASD | 11 (42%) | 0 (0%) |
| Non-ASD | 14 (54%) | 15 (100%) |
| Unknown | 1 (4%) | 0 (0%) |
| ADOS | ||
| Completed | 22 (85%) | 0 (0%) |
| Comparison score | 6.05 (2.54) | – |
| Vineland | ||
| Completed | 25 (96%) | 0 (0%) |
| Adaptive behavior composite standard score | 52.8 ± 13.4 | – |
| Communication composite standard score | 58.0 ± 14.6 | – |
| SSP | ||
| Completed | 22 (85%) | 3 (20%) |
| Total score | 143.9 ± 16.5 | 178.7 ± 17.1 |
| RBS-R | ||
| Completed | 23 (88%) | 0 (0%) |
| Total score | 16.26 ± 15.7 | – |
| MSEL | ||
| Completed | 16 (61.5%) | 0 (0%) |
| NVIQ | 19.98 ± 10.9 | – |
| SB5 | ||
| Completed | 9 (34.6%) | 0 (0%) |
| NVIQ | 46.56 ± 7.5 | – |
| DAS | ||
| Completed | 2 (7.7%) | 0 (0%) |
| NVIQ | 73.50 ± .71 | – |
| NVIQ | ||
| Completed | 25 (96%) | 0 (0%) |
| Non-verbal intelligence quotient | 31.4 ± 17.9 | – |
| Seizure history | ||
| Yes | 4 (15.4%) | – |
| No | 21 (80.8%) | – |
| Unknown | 1 (3.8%) | 15 (100%) |
| SHANK3 | – | |
| Mutation | 7 (26.9%) | – |
| Deletion | 19 (73.1%) | – |
| Deletion size (mega base pairs) | 3.95 ± 3.0 | – |
Categorical variables (i.e. yes, no) are presented as the number in each category, followed by the percentage in each category. Continuous variables are presented as the mean value ± their standard deviation. *No EEGs from University of Texas Southwestern retained enough data after artifact rejection to be analyzed